167 related articles for article (PubMed ID: 1610857)
21. Severe cardiac allograft dysfunction without endomyocardial biopsy signs of cellular rejection: incidence and management.
Veiga Barreiro A; Crespo Leiro M; Doménech García N; Paniagua MJ; Vázquez Martul E; González Cuesta M; Ramírez C; Juffé Stein A; Castro Beiras A
Transplant Proc; 2004 Apr; 36(3):778-9. PubMed ID: 15110660
[TBL] [Abstract][Full Text] [Related]
22. Donor-derived human leukocyte antigen class I proteins in the serum of heart transplant recipients.
DeVito-Haynes LD; Jankowska-Gan E; Heisey D; Jutte NH; Balk AH; Weimar W; Claas FH; Warner TF; Mentzer RM; Love RB; Burlingham WJ
J Heart Lung Transplant; 1996 Oct; 15(10):1012-26. PubMed ID: 8913919
[TBL] [Abstract][Full Text] [Related]
23. [Humoral rejection in heart transplantation. Report of 2 cases].
Castro P; Arriagada G; Moreno M; Morán S; Becker P; Zalaquett R; Godoy I; Córdova S
Rev Med Chil; 2000 Nov; 128(11):1245-9. PubMed ID: 11347512
[TBL] [Abstract][Full Text] [Related]
24. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation.
White JA; Guiraudon C; Pflugfelder PW; Kostuk WJ
J Heart Lung Transplant; 1995; 14(6 Pt 1):1052-6. PubMed ID: 8719450
[TBL] [Abstract][Full Text] [Related]
25. Antibody-mediated rejection without acute graft dysfunction in adult ABO-compatible heart transplantation: a case of accommodation.
Angelini A; Castellani C; Poli F; Benazzi E; Torregrossa G; Tona F; Gambino A; Caforio AP; Feltrin G; Toscano G; Valente M; Thiene G; Gerosa G
J Heart Lung Transplant; 2008 Dec; 27(12):1357-60. PubMed ID: 19059119
[TBL] [Abstract][Full Text] [Related]
26. Heart allograft rejection under varying immunosuppressive protocols as evaluated by endomyocardial biopsy.
Imakita M; Tazelaar HD; Billingham ME
J Heart Transplant; 1986; 5(4):279-85. PubMed ID: 3305819
[TBL] [Abstract][Full Text] [Related]
27. [Intramyocardial electrocardiogram (IMEG) in diagnosis of humoral rejection after heart transplantation].
Grauhan O; Müller J; Knosalla C; Pfitzmann R; Cohnert T; Siniawski H; Volk HD; Fietze E; Hetzer R
Z Kardiol; 1996 Oct; 85(10):745-52. PubMed ID: 9036700
[TBL] [Abstract][Full Text] [Related]
28. Should we be doing routine biopsy after heart transplantation in a new era of anti-rejection?
Patel JK; Kobashigawa JA
Curr Opin Cardiol; 2006 Mar; 21(2):127-31. PubMed ID: 16470149
[TBL] [Abstract][Full Text] [Related]
29. Grade 2 cellular heart rejection: does it exist?: Yes!
Kemnitz J
J Heart Lung Transplant; 1995; 14(4):800-1. PubMed ID: 7578197
[No Abstract] [Full Text] [Related]
30. Evidence for antibody and immune-complex deposition in heart transplantation: a report of three cases.
Shumakov VI; Beletskaya LV; Baranova FS; Mogilevsky GM; Chestukhin VV; Kormer AYa ; Kazakov EN; Khubutia AS; Kurenkova LG; Khalimova ZA
J Heart Lung Transplant; 1992; 11(6):1209-12. PubMed ID: 1457448
[TBL] [Abstract][Full Text] [Related]
31. Cytoimmunologic monitoring as an adjunct in monitoring rejection after heart transplantation: results of a 6-year follow-up in heart transplant recipients.
Wijngaard PL; Doornewaard H; van der Meulen A; Plomp S; Gmelig Meyling FH; de Jonge N; Schuurman HJ
J Heart Lung Transplant; 1994; 13(5):869-75. PubMed ID: 7803429
[TBL] [Abstract][Full Text] [Related]
32. Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipients.
van Gelder T; Mulder AH; Balk AH; Mochtar B; Hesse CJ; Baan CC; Vaessen LM; Weimar W
J Heart Lung Transplant; 1995; 14(2):346-50. PubMed ID: 7779855
[TBL] [Abstract][Full Text] [Related]
33. Timing of the first endomyocardial biopsy in heart transplantation after induction immunosuppressive therapy--experience from Canadian Heart Transplant Centre.
Málek F; Kaan A; Straatman L; Cheung A; Gnaszewski A
Cas Lek Cesk; 2005; 144(8):507-9; discussion 509. PubMed ID: 16173602
[TBL] [Abstract][Full Text] [Related]
34. The significance of eosinophils in mild and moderate acute cardiac allograft rejection.
Gollub SB; Huntrakoon M; Dunn MI
Am J Cardiovasc Pathol; 1990; 3(1):21-6. PubMed ID: 2331359
[TBL] [Abstract][Full Text] [Related]
35. Humoral rejection in pediatric orthotopic heart transplantation.
Casarez TW; Perens G; Williams RJ; Kutay E; Fishbein MC; Reed EF; Alejos JC; Levi DS
J Heart Lung Transplant; 2007 Feb; 26(2):114-9. PubMed ID: 17258143
[TBL] [Abstract][Full Text] [Related]
36. Acute rejection and heart infection rates in FK 506- versus cyclosporine A-treated heart transplant recipients: an endomyocardial biopsy pathologic study.
Arbustini E; Dal Bello B; Rinaldi M; Diegoli M; Grasso M; Pellegrini C; Morbini P; Martinelli L; Bonora MR; Viganò M
J Heart Lung Transplant; 1997 Sep; 16(9):982-4. PubMed ID: 9322152
[No Abstract] [Full Text] [Related]
37. Influence of rejection on late graft function after heart transplantation.
Livi U; Milano A; Caforio AL; Grassi G; Feltrin G; Boffa GM; D'Agnolo A; Angelini A; Thiene G; Casarotto D
Transplant Proc; 1994 Oct; 26(5):2727-8. PubMed ID: 7940855
[No Abstract] [Full Text] [Related]
38. Endothelin plasma levels in acute graft rejection after heart transplantation.
Dengler TJ; Zimmermann R; Tiefenbacher CP; Braun K; Sack FU; Kübler W
J Heart Lung Transplant; 1995; 14(6 Pt 1):1057-64. PubMed ID: 8719451
[TBL] [Abstract][Full Text] [Related]
39. The role of right ventricular endomyocardial biopsy in the long-term management of heart-lung transplant recipients.
Glanville AR; Imoto E; Baldwin JC; Billingham ME; Theodore J; Robin ED
J Heart Transplant; 1987; 6(6):357-61. PubMed ID: 3121820
[TBL] [Abstract][Full Text] [Related]
40. Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival.
Gonzalez-Stawinski GV; Cook DJ; Chang AS; Banbury MK; Navia JL; Hoercher K; Lober C; Atik FA; Taylor DO; Yamani MH; Young JB; Starling RC; Smedira NG
J Heart Lung Transplant; 2006 Jun; 25(6):613-8. PubMed ID: 16730565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
